Elizabeth Knight

elizabeth knight profile image

Elizabeth Knight

National Clinical and Donor Research Manager
Donor Behaviour Research Group  Donor Health and Wellbeing Research Group 
Connect with Elizabeth Knight Email LinkedIn Research Gate

Elizabeth works across a number of R&D projects/ activities and manages a diverse team of researchers who collectively form the Donor Research team. The Donor Research team strives to build the sustainability of the donor panel, maintain their health and well being as well as contribute to research performed by external collaborators in Healthcare.

Elizabeth completed her Masters degree in Public Health at the University of Wollongong and went on to gain more than 15 years’ experience working in clinical trials, both locally and overseas, including more than three years for the University of British Columbia in Vancouver, Canada working on Hepatitis C treatment for current and former Injection Drug Users. On joining Lifeblood Elizabeth lead the first trial in Donors direct to Plasma, the ADOPT study.

Member
  • Association of Regulatory and Clinical Scientists (ARCS) Professional Development In Therapeutics

Key Publications

Evaluation of a sterile surgical skin marker to indicate the optimal vein for venepuncture in the blood donation setting.
Bell B, O'Donovan J, Wright ST, Gemelli CN, Knight E, Hirani R.
2020
Vox Sanguinis
115:377-387
View publication
Evaluation of a tool to score donor vein suitability for blood donation.
Hirani R, O'Donovan J, Knight E, Bell B, Mondy P.
2019
Vox Sanguinis
114(6):588-594
View publication

Elizabeth Knight articles

illustration of four people in white lab coats
Research study update: Beyond the iron gate

People with Hereditary haemochromatosis (HHC) who donate at Lifeblood reported that they feel more like donors than patients. This suggests that Lifeblood could change the way we communicate with them, as we currently communicate with them as “patients”. They did not know much about plasma and had mixed views on being able to donate plasma.

Find out more
illustration of a donor holding a red blood droplet, standing next to them is a scientist in a white lab coat, in the background is a microscope
Research study update: ASPECT study | Antigen specific T cells for COVID-19 Therapy and the Therapeutic cell bank

Lifeblood researchers, with the help of a small number of very dedicated donors, were able to contribute to some amazing work on novel COVID-19 therapies being conducted by Associate Professor Emily Blyth and her team in the Westmead T-Cell Therapies Group (WTCG) at the Westmead Institute for Medical Research.

Find out more